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Abstract
Background: Sputum culture is the gold standard for diagnosis of pulmonary tuberculosis (PTB). Although mostly used for
research, culture is recommended by the World Health Organization for TB diagnosis among HIV infected smear negative
PTB suspects. Even then, the number of sputum samples required remains unspecified. Here, we determined the
Incremental Yield (IY) and number of samples required to diagnose an additional PTB case upon second and third serial
sputum culture.
Methods/Findings: This was a cross sectional study done between January and March 2011. Serial sputum samples were
provided by participants within two days and cultured using Lowenstein Jensen (LJ) and Mycobacteria Growth Indicator
Tube (MGIT) methods. A PTB case was defined as a positive culture on either one or both methods. The IY from the second
and third serial cultures was determined and the reciprocal of the product of the fractions of IY provided the number of
samples required for an additional PTB case. Of the 170 smear negative PTB suspects, 62 (36.5%) met the case definition.
The IY of the second sample culture was 12.7%, 23.6% and 12.6% and for the third sample culture was 6.8%, 7.5% and 7.3%
with LJ, MGIT and LJ or MGIT, respectively. The number of samples required for an additional PTB case and 95% CI upon the
second sample culture were 29.9 (16.6, 156.5), 11.3 (7.6, 21.9) and 20.8 (12.5, 62.7); while for the third sample culture were
55.6 (26.4, 500.4), 35.7 (19.0, 313.8) and 36.1 (19.1, 330.9) by LJ, MGIT and LJ or MGIT respectively.
Conclusions/Significance: Among HIV infected smear negative PTB suspects in Kampala, 93% of PTB cases are
diagnosed upon the second serial sputum culture. The number of cultures needed to diagnose an additional PTB case,
ranges from 11–30 and 35–56 by the second and third sputum samples, respectively.
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Introduction
SPUTUM CULTURE remains the gold standard for diagnosis
of pulmonary tuberculosis (PTB). Although mainly used for
research, culture is recommended by the World Health Organi-
zation (WHO) for TB diagnosis among HIV-infected smear
negative PTB suspects [1].
Several studies have documented the usefulness of sputum
culture among HIV-infected smear negative TB suspects. Smear
negative, culture positive TB prevalence ranged from 32% to
56% [2,3,4]. However, the number of samples required for
sputum culture remains unspecified despite the resource
constraints. There is only one public TB culture facility in
Uganda, where culture is mainly done to rule out drug resistant
TB. There have been advances in decentralizing sputum culture
services so that they are more accessible; however, evidence-
based means and best practices towards their efficient use have
not been fully explored [5].
Some of the limitations towards realized access to the existing
TB culture facilities are the operational costs. One of the ways to
reduce this gap could be determining the optimal number of
sputum samples to be cultured. There are variations in the
number of sputum samples submitted for culture as a result of
trying a trade-off between cost and increase in TB case detection
[6,7,8].
Reducing the number of sputum specimens and clinic visits
for diagnosis in settings with high prevalence of TB and HIV
could reduce resources needed and workload for laboratory
staff, with improved compliance to sputum sample collection
procedures [9].
In this current study, we determined the Incremental Yield
(IY) and the number of sputum samples required for an
additional PTB case upon second and third serial sputum
sample culture among HIV infected smear negative PTB suspects
in order to inform practice and efficient use of the available TB
culture resources.
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Out of the 203 PTB suspects, 22 (10.8%) did not consent and 11
(5.4%) turned positive on repeated smear microscopy. We
analyzed results from 170 (84.0%) smear negative PTB suspects
and their characteristics are summarized in Table 1. Among the
eligible participants, 104 (61.2) were in WHO HIV/AIDS clinical
stage 2, 36 (21.2%) were in stage 3, 30 (17.6%) were in stage 1 and
86(50.6%) of the participants were on Anti Retroviral Therapy
(ART).
Of the 170 participants, 20 (11.7%) failed to submit the second
and/or the third sputum sample; thus, a total of 461 (90.4%)
sputum samples were analyzed. Sixty-nine (16.4%) became
contaminated upon MGIT culture, of which 25 (36.2%) were
first, 35 (50.7%) second and nine (13.1%) third sputum samples. A
contamination rate of 2% was documented on LJ. All contami-
nated samples were categorized as negative during the analysis,
Table 1.
Of the 170 participants, 43 (25.3%), 60 (35.3%) and 62 (36.5%)
were culture positive for MTBC using LJ alone, MGIT alone and
LJ or MGIT, respectively.
Out of the 62 culture positive participants, four (2.4%) had both
MTBC and Mycobacterium Other Than Tuberculosis (MOTT)
hence met the TB case definition. Females and males were equally
likely to be culture positive, p=0.285, Table 1.
All participants who submitted at least one sample for culture
were considered in the analysis while catering for the probability of
those samples missed being positive when the previously cultured
sample (s) were negative. Majority of the PTB cases were detected
on the first and less were detected by the third sputum sample
culture. Table 2 shows the results obtained by sputum culture in
six different patterns according to sample number.
The patterns from table 2 were used to determine the IY for the
second and third sputum samples for each culture method and
when both methods were combined.
The IY of the second and third sputum sample culture were
12.7% and 6.8% on LJ, 23.6% and 7.5% on MGIT and 12.6%
and 7.3% on LJ or MGIT culture methods respectively, Table 3.
Therefore, on average, 80%, 13%, and 7% of the TB cases where
detected on the first third sputum sample cultures respectively.
This indicates that 93% of the TB cases are detected upon a second
sputum sample culture.
The number of samples needed to find one additional case and
their 95% CI by the second and third sputum culture for LJ was
29.9 (16.6, 156.5), 55.6 (26.4, 500.4), MGIT11.3 (7.6, 21.9), 35.7
(19.0, 313.8) and using LJ or MGIT 20.8 (12.5, 62.7) and 36.1
(19.1, 330.9) respectively. These were compared with the
maximum number from the TB expert opinions taken as the
critical values, Table 4.
Discussion
This cross-sectional study reveals that among HIV-infected
smear negative PTB suspects in Kampala Uganda, the prevalence
of PTB was 36.5%. More than 93% of these cases were diagnosed
with two serial sputum sample culture. The number of sputum
samples needed to be examined to identify an additional PTB case
ranged from 11–30 samples, by the second and 35 –56 samples by
the third sputum sample culture. The number of samples by the
3rd sputum culture exceeded what the TB experts suggested as
acceptable maximum number i.e. 17 samples.
Previous studies done among HIV infected patients documen-
ted similar PTB prevalence among smear negative TB suspects;
a study done Thailand and Vietnam showed a PTB prevalence of
32% [2] and in Zimbabwe a prevalence of 39.4% was documented
[4]. However a study done in Uganda [3] documented PTB
prevalence of 56%, probably it considered only admitted patients
who were more likely to have more cavities than the participants in
the previous studies as well as this study.
In HIV symptomatic patients with at least two negative sputum
smears and one culture negative, it is important to question if
culture is more helpful than clinical evaluations and if it is worth
the effort to ask for a second culture if the physician is still
considering TB after all those negative results.
Using LJ, less numbers of PTB cases were detected; 43 (69.3%)
compared to MGIT method; 60 (96.7%). This difference is mainly
due to the fact that MGIT, which is a liquid culture system, is
more sensitive but also more prone to contamination than LJ
method, which is a solid culture system, as also documented in
other studies [2,10,11]. The differences in proportions of PTB
cases found in this population using different culture methods
among different sputum sample cultures suggest that locally
designed studies are needed to determine the value of the serial
sputum samples [12,13]. The high contamination rate of MGIT
culture, not only increase the cost for culture, but also leads to
under estimation of prevalence of PTB obtained from MGIT
method as all contaminated cultures were classified as negative
during the analysis.
Table 1. Prevalence of pulmonary tuberculosis (PTB) among sputum smear negative HIV infected TB suspects (n=170).
Category Parameter Culture positive/TB cases (n=62) Culture negative (n=108)
Gender Females 34 (54.8%) 68 (63.0%)
Males 28 (45.2%) 40 (37.0%) P=0.285
Age Mean (SD) 36.5(9.4)
Median (IQR) 35(32–37)
Age groups (Years) 20–30 21 (33.9%) 31(28.7%)
31–40 24 (38.7%) 45(41.7%)
41–50 13 (21.0%) 21(19.4%)
51–60 4 (6.5%) 7(6.5%)
61–70 0 (0.0%) 2(1.9%)
Unknown 0 (0.0%) 2(1.9%)
SD=Standard Deviation, IQR=Inter Quartile Range.
doi:10.1371/journal.pone.0037650.t001
Incremental Yield of Serial Sputum Cultures
PLoS ONE | www.plosone.org 2 May 2012 | Volume 7 | Issue 5 | e37650The IY of the second and third sputum sample culture
documented by this study also agrees with the previous studies.
A study conducted in Thailand and Vietnam among HIV infected
persons [2] documented an IY by LJ method of 14%; 95% CI 9–
22, and 6%; 95% CI 3–12) for the second and third sputum
sample cultures respectively as compared to IY by MGIT method
of 17%; 95% CI 11–24 and IY 10%; 95%CI5–16, for the second
and third sputum cultures respectively. However, David Moore
et al documented minimal gain (only in IY) from the second
sputum sample culture and did not consider a third sputum sample
culture [14]. These studies, however, did not analyze the IY for LJ
or MGIT which is a common practice in some countries. The
increased yield of the second MGIT culture could be partly due to
the second culture detecting the first contaminated cultures;
however, contamination is unlikely to fully explain the IY in
MGIT because this increased yield was also observed by other
studies with lower contamination rates [2,14].
Furthermore, previous studies have urged that more than two
sputum samples are not worthy being examined comparing the
diagnostic gain vis-a `-vis the burden to scarcity of human resource,
financial constraints, limited laboratory facilities and high work-
load, which could in turn affect the quality of the results obtained
from the third sputum sample examination [12,6].
Although these studies were not using sputum culture and were
done in both HIV infected and non-HIV infected patients, they
are in agreement with this study as the incremental yield from the
third sputum sample for resource limited settings cannot justify its
examination.
There was no literature and this study did not evaluate the cost
effectiveness to support the number of sputum sample cultures
required to detect one additional PTB case on the second and
third sputum culture among HIV infected smear negative PTB
suspects hence this study sought for expert opinions. However, the
observed number of samples needed to be examined to identify an
additional PTB case ranged from 11–30 samples by the second
sample culture, and 35–56 samples by the third sputum sample
culture. The number of samples by the 3rd sputum culture
exceeded the 17 samples suggested by the TB experts as
acceptable. Based on these findings, two sputum sample cultures
may be optimal. However, it is worth noting that the number of
sputum samples required for an additional PTB case depends on
the prevalence of TB in a given population and the ability to
correctly suspect a TB case. In areas were TB prevalence is lower
than in the current study, the number required for the second and
third sputum cultures could be higher. This could further reduce
the justification for the third and even the second sputum sample
culture.
This study findings could add significant information towards
the practices especially in Uganda where varying number of
sputum samples (1 to 3) are collected for TB culture, as well as to
the global policy formulations as it was previously documented to
improve access and efficiency through reduced workload which in
turn improves quality [15].
We recommend that country’s TB programs adopt two sputum
samples for culture, however, a bigger study to look at patient
outcomes and cost-effectiveness of our findings may be needed.
Furthermore, given the wide variation of the necessary resources
and operational costs for TB culture, it is essential to employ
appropriate recommendations and policies locally. Settings with
Table 2. Distribution of sputum sample culture results for the six patterns of results according to methods used.
Pattern of result LJ alone n (%) MGIT alone n (%) LJ or MGIT n (%)
Px 36 (21.2) 44 (25.9) 52 (30.6)
NPx 5 (2.9) 13 (7.7) 7 (4.2)
NNP 2 (1.2) 3 (1.7) 3 (1.7)
NNN 82 (48.2) 67 (39.4) 67 (39.4)
NN9 29 (17.1) 26 (15.3) 24 (14.1)
N99 16 (9.4) 17 (10.0) 17 (10)
Total patterns/patients: 170 170 170
PX=positive on the first sample, x=the next result adds no more diagnostic value, N=Negative, 9=missing, LJ (Solid culture)=Lowenstein Jensen, MGIT (Liquid
culture)=Mycobacterium Growth Indicator Tube.
doi:10.1371/journal.pone.0037650.t002
Table 3. Yield of first and Incremental yield of the second and
third serial sputum culture.
Observed and expected incremental
yield LJ MGIT
LJ or
MGIT
Observed yield from 1st sputum culture: 0.212 0.259 0.306
Observed yield from 2nd sputum culture: 0.042 0.119 0.069
Observed yield from 3rd sputum culture: 0.024 0.043 0.043
Total positives observed 43 60 62
Missed TB cases %¥
Positives missed by not doing a 2nd sputum
culture
0.7 2.0 1.2
Positives missed by not doing a 3rd sputum
culture
1.1 1.8 1.7
Total positives missed 1.8 3.8 2.9
Expected yield from 3 sputum cultures (Exp)p 44.8 63.8 64.9
Expected Yield (Fraction){
Observed pattern (n) + missed TB cases/Exp 1.000 1.000 1.000
Expected from the first sputum culture{1 0.805 0.690 0.801
Expected from second sputum culture {2 0.127 0.236 0.126
Expected from third sputum culture{3 0.068 0.075 0.073
LJ (Solid culture)=Lowenstein Jensen, MGIT (Liquid culture)=Mycobacterium
Growth Indicator Tube.
¥=Number of estimated TB cases missed among those who never submitted
the 2
nd and 3
rd sputum sample for culture, assuming a same proportion of TB
cases as in those who submitted the 2
nd and 3
rd sputum for culture,
respectively. {=The proportion of TB cases expected if each of the suspects
had a complete set of three sputum cultures, P=Total positives observed +
total positives missed, {1=Px/Exp, {2=NPx + missed by second/ExP and
{3=NNP + missed by third/Exp.
doi:10.1371/journal.pone.0037650.t003
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rd sputum sample
using culture as the IY of 7% may not easily be ignored especially
among HIV infected persons where early diagnosis is paramount
mainly before ART initiation.
Previous studies were done in general HIV population
irrespective of their smear results, and few have looked at the
gain from the different sputum samples [2,3]. This gives our study
strength since it was conducted in an HIV infected smear negative
TB and applied special analytical techniques to determine the
yield of each sputum sample culture.
Previous studies among smear negative patient also did not
analyze their results to find out the number of cultures needed to
find an additional TB case in a given population considering the
first, second and third sputum sample cultures.
Limitations
We acknowledge the small sample size due to limited resources;
but being the first of its kind in the country and in this study
population, the findings of this study may be important for studies
aiming at larger sample sizes.
This study was also conducted in a research setting with special
attention to sample transportation and processing as expected in
a clinical research laboratory hence the findings of this study may
not reflect the routine. The study analysis considered all
contaminated results as negative; this could have underestimated
the TB prevalence in the study population.
It is also worth noting that we did not follow those who were
negative as per the national TB guidelines. Furthermore, future
studies to look at the gain from two serial sputum sample cultures
collected on the same day ‘‘Front-loading’’ may be necessary as
patients will only make one visit to the health facility and also may
increase adherence to sputum collection and efficiency.
Methods
This study was approved by the Higher Degree Research and
Ethics Committee (HDREC) of Makerere University School
Public Health, Kampala and the Uganda National Council of
Science and Technology (UNCST). All participants provided
a written informed consent before participating in this study. The
aim of this study was to determine the incremental yield and the
number of sputum samples needed to find an additional PTB case
by culture on the second and third serial sputum sample among
HIV infected smear negative PTB suspects in Kampala, Uganda.
Hypothesis
Since there was no literature on the number of samples required
for an additional PTB case, five international experts in
mycobacteriology and/or public health TB control programs,
who were not involved in the current study, were requested for
their opinion on the number of samples. The maximum number of
samples for the second sputum was 12, while for the third was 17
samples.
We therefore hypothesized that not more than 12 sputum
cultures by the second and 17 by the third sputum sample are
needed to be examined for an additional PTB case with a second
and third serial diagnostic sputum culture.
Study Setting
All participants were HIV positive and managed according to
the WHO HIV/AIDS clinical stages with some center having
capacity for CD4 counts. Participants were from three HIV care
clinics and one general TB ward of Mulago National referral
hospital in Kampala, Uganda (Infectious Diseases institute,
Makerere- Mbarara Joint Aids Project [MJAP], in patient wards
4A, and general TB ward 5 and 6). In these clinics all PTB
suspects are screened basing on clinical signs and symptoms
together with chest X-ray and diagnosed by sputum smear
microscopy using Ziehl Neelsen (ZN) method.
Study Design
This was a cross-sectional study in which a total of 203
participants were screened and only 181 enrolled. Those eligible
were male and female HIV-infected, at least 18 years and above,
with cough for more than two weeks and at least two negative
sputum smears and no history of PTB treatment. Participants were
instructed to take a deep breath and cough to provide an on spot
sputum sample and given another container to provide an early
morning sample. On the following day after delivering early
morning sputum sample, a third spot sputum sample was
provided.
Laboratory Methods
At the participating clinic laboratories, sputum smear
microscopy was performed on these samples using standard
ZN method [16]. Following smear microscopy, sputum samples
from participants with three negative samples were briefly stored
at 2–8uc and transported to the laboratory, in a box with ice
packs, for culture.
Table 4. Comparison of Number of sputum samples required to detect one additional TB case on 2
nd and 3
rd sputum culture
versus TB expert critical values.
Culture method
First sample culture
(spot specimen)
n (95% CI)
a
Second sample culture
(morning specimen)
n (95% CI)
b
Expert opinion on
2nd sample culture
Third sample culture (spot
specimen)
n (95% CI)
c
Expert opinion on
3rd sample culture
LJ alone 4.7 (3.7–6.7) 29.9 (16.6–156.5) 2
1,3
2,3,1 0
4,1 2m
5 55.6 (26.4–500.4) 3
2,3,5
1,1 7m
5
MGIT alone 3.9 (3.1–5.2) 11.3 (7.6–21.9) 2
1,3
2,3,1 0
4, 12 m
5 35.7 (19.0–313.8) 3
2,3,5
1,1 7m
5
LJ plus MGIT 3.3 (2.7–4.2) 20.8 (12.5–62.7) 2
1,3
2,3,1 0
4,1 2m
5 36.1 (19.1–330.9) 3
2,3,5
1,1 7m
5
LJ (Solid culture)=Lowenstein Jensen, MGIT (Liquid culture)=Mycobacterium Growth Indicator Tube.
1Derek Armstrong,
2Richard Oatis,
3John Kenneth
4,Armand Van Deun,
5Nicole Parrish;
Order has no superiority meaning.
,=the third sample was not necessary and could not recommend for it to be examined.
CI=Confidence Interval.
a
=1/Px*170,
b=1/NPx +positive missed by second*170 and
c=1/NNP + positive missed by third * 170, m=Expert opinion Critical value for the second and third sputum
sample culture.
doi:10.1371/journal.pone.0037650.t004
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was repeated [16]. Participants whose results turned positive on
repeat where excluded, however, their smear results were
communicated for patient management.
Sputum culture. All samples from smear negative partici-
pants were cultured according to standard operating procedures.
All cultures were incubated till 8 weeks on LJ (Becton and Dickson,
Franklin Lakes, NJ USA) [17] and six weeks in the BD
BACTEC
TM MGIT
TM 960 (Becton and Dickson, Franklin
Lakes, NJ USA) system [18]. For identification of Mycobacterium
tuberculosis complex (MTBC), cultures in which mycobacteria grew
were subjected to Capilia TB Neo
TM (TAUN, Numazu, Japan)
assay as described in elsewhere [19,20].
A participant’s culture result was considered contaminated if the
LJ slants or MGIT cultures from all specimens revealed growth of
organisms other than mycobacteria; otherwise, a positive result
was taken as at least a single colony on solid media, or a single
positive MGIT culture that revealed AFB on ZN microscopy and
was positive upon Capilia TB Neo
TM. The absence of colonies on
LJ medium or fluorescence on MGIT was reported as a negative
result. All results were entered into a computerized laboratory
access database and linked with patient records on the sample
reporting form.
Quality assurance. Internationally acceptable quality con-
trol procedures for TB diagnosis were implemented at each
collection site e.g. sputum container quality, proper sputum
collection, precautions given to participants to avoid sample
contamination at pre-analytical (sputum quantity and quality plus
proper labeling).
Analytical quality procedures included; quality control of strains
to confirm growth of AFB as well as staining with known positive
and negative controls and checking the media quality using control
strains (H37Rv ATCC 27294; M. kansasii, ATCC 12478;
M. fortuitum, ATCC 6841). We also included artificial sputum (a
dummy sterile sample made of eggs and Methylcellulose, Sigma-
Adrich MO267) in each batch of 12 samples to rule out cross-
contamination. At post-analytical stages of the laboratory
procedures, control measures such as proof reading were taken
to minimize chances of false-results.
Data Management
Data were crosschecked on the data collection forms for
completeness before entry into a computer in an excel sheet and
quality controlled by checking 10% of the entered records to
resolve discrepancies. Data were analyzed using Stata SE software,
(version 11, Stata Corp LP, College station TX 77849, USA), for
descriptive statistics. The unit of analysis was the sample type (spot,
morning, spot) and a p-value ,0.05 was considered significant.
The potential IY and the number of samples required to identify
an additional PTB case was analyzed according to Ipuge Y et al
(1996) [21] using an already developed excel database that was
used in previous studies [7,22].
The first step involved calculation of the proportion of suspects
positive by each of the sputum culture done i.e. 1
st,2
nd and 3
rd.
A case was a person who was positive by any of the sputum
cultures i.e. LJ, MGIT or a combination of both.
In a second step, the potential incremental yield from serial
sputum culture was calculated.
Proportion of suspects positive on the 1
st,2
nd and 3
rd
sputum culture. Not all patients managed to submit the
required three serial sputum samples; therefore we categorized
results into six patterns: Px, NPx, NNP, NNN, NN9, N99.
Where P was a positive culture result, x a subsequent result of no
interest, N a negative result, and 9 a missing result.
The fraction of persons who were found positive on the first
sputum culture was denoted as Sd1: Sd1=Px/
(Px+NPx+NNP+NNN+NN9+N99).
The numerator comprised those suspects who were positive on
the first sputum culture, i.e., Px.
The denominator comprised those suspects with at least the first
sputum culture done.
The fraction of persons who were found to be negative on the
first sputum culture but positive on the second was denoted as Sd2:
Sd2=NPx/(NPx+NNP+NNN+NN9).
The fraction of those who were found to be positive only on the
third sputum culture (negative on the first and second) was
denoted as Sd3: Sd3=NNP/(NNP+NNN).
To calculate the incremental yield, the assumption made was
that those with an N99 result had the same probability of being
positive on the second sputum culture as those with an NPx result,
and those with a NN9 result the same on the third sputum culture
as those with a NNP result. Those (positive) who were missed by
failing to do a second sputum culture were denoted as Md2 and
those (positive) who were missed by failing to do the third sputum
culture were denoted as Md3, and the total (positive) missed by
doing neither the second nor the third was denoted as Md.
For Md2 we obtain: Md2=S d2 * N99. Calculating Md3 took
into account both those who were missed the second and those
who missed the third sputum culture:
Md3=S d3 * (NN9=(1 - Sd2) * N99), then:
Md=M d2+Md3,
thus, the observed (recorded) number of positive Od:
Od=Px+NPx+NNP and the expected number of positive Ed,
calculated from the observed and the missed was: Ed=O d+Md.
The expected proportion positive was: Rd=E d/Ad, (Ad=Num-
ber of suspects).
Next, the fractions for the potential yield from the first (Fd1), the
potential incremental yield on the second (Fd2), and the third (Fd3)
sputum cultures were calculated:
Fd1=Px/Ed, Fd2=(M d2+NPx)/Ed, Fd3=(M d3+NNP)/Ed.
In the final step, the product of the expected proportion positive
(Rd) was multiplied by each potential incremental fraction (Fd1,
Fd2 and Fd3) to give the overall fraction positive on the respective
sputum culture.
The reciprocal values of the products of (Fd2 and Fd3) gave the
number of sputum culture needed to find one (additional) case on
the second and on the third sputum culture considering those
missed by not doing the second and the third sputum culture.
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